Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Janssen Pharmaceutica discloses novel estrogen-related receptor-alpha ligands

Dec. 27, 2011

Galaczym obtains new orphan drug status

Dec. 23, 2011

Novel somatostatin sst5 receptor antagonists synthesized

Dec. 23, 2011

New 11-beta-HSD1 inhibitors developed in Korea

Dec. 23, 2011

Novel GPR119 receptor agonists discovered in Japan

Dec. 23, 2011

DiaMedica's humanized MAb for type 2 diabetes shows improved binding affinity

Dec. 23, 2011

Canadian university prepares new prostanoid EP4 receptor agonists

Dec. 22, 2011

Enrollment complete in first phase III migalastat hydrochloride trial

Dec. 22, 2011

Trimel Pharmaceuticals announces completion of phase II TBS-2 trial in anorgasmia

Dec. 22, 2011

Ardea Biosciences initiates phase III lesinurad program

Dec. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...